Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Cytokine blocking agents in dermatology.

J D L Williams¹, C E M Griffiths

¹The Dermatology Centre, University of Manchester, Hope Hospital, Salford, Manchester, UK. jasondwilliams@hotmail.com

Clinical and Experimental Dermatology

|December 5, 2002

Summary

Cytokine-targeted therapies show promise for treating inflammatory skin diseases. Blocking tumor necrosis factor alpha is effective for psoriasis and other conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Retinoids in the treatment of photoageing: A histological study of topical retinoid efficacy in black skin.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024

Same author

Tofacitinib efficacy, patient-reported outcomes and safety in patients with psoriasis and a medical history of psoriatic arthritis: Pooled analysis of two Phase III studies.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024

Same author

Immunogenicity and pharmacokinetics of guselkumab among patients with moderate-to-severe psoriasis in VOYAGE-1 and VOYAGE-2.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023

Same author

Influence of menopause and hormone replacement therapy on epidermal ageing and skin biomechanical function.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022

Same author

Tender facial nodules in a man receiving adalimumab for psoriasis.

Clinical and experimental dermatology·2021

Same author

Restoration of collagen and elastic fibre networks following treatment of photoaged skin with Serènesse, a novel over-the-counter anti-ageing product.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021

Area of Science:

Immunodermatology
Molecular biology of skin inflammation
Therapeutic targeting of cytokines

Background:

Cytokines are key intercellular messengers in cutaneous inflammation.
Their central role in immune responses makes them attractive therapeutic targets.
Targeting cytokines for skin diseases is an emerging therapeutic strategy.

Purpose of the Study:

To review the current and prospective roles of cytokine-blocking agents in dermatology.
To highlight the therapeutic potential of targeting cytokines in skin disease management.

Main Methods:

Review of existing literature on cytokine-targeted therapies for skin conditions.
Analysis of clinical data for agents blocking tumor necrosis factor alpha.
Discussion of anecdotal evidence for other dermatological applications.

Main Results:

Blocking tumor necrosis factor alpha (TNF-α) with infliximab or etanercept shows significant promise.
These agents are particularly effective in managing psoriasis.
Anecdotal evidence suggests efficacy in pyoderma gangrenosum and Behçet's syndrome.

Conclusions:

Cytokine-blocking agents represent a promising frontier in dermatological treatment.
Targeting TNF-α is a validated approach for specific inflammatory skin diseases.
Further research into cytokine-targeted therapies is warranted for broader dermatological applications.

Related Experiment Videos